MAGRILAN

This brand name is authorized in Cyprus, Hong Kong, Lithuania, Malta, Romania, Singapore

Active ingredients

The drug MAGRILAN contains one active pharmaceutical ingredient (API):

1 Fluoxetine UNII I9W7N6B1KJ - FLUOXETINE HYDROCHLORIDE

Fluoxetine is a selective inhibitor of serotonin reuptake, and this probably accounts for the mechanism of action. Fluoxetine has practically no affinity to other receptors such as α1, α2, and β-adrenergic; serotonergic; dopaminergic; histaminergic1; muscarinic; and GABA receptors. Read about Fluoxetine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MAGRILAN Hard capsule	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AB03	Fluoxetine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AB Selective serotonin reuptake inhibitors
Discover more medicines within N06AB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 35706
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003503
Country: MT	Medicines Authority	Identifier(s): MA032/05301
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W08497001
Country: SG	Health Sciences Authority	Identifier(s): 05766P